Tigecycline for Injection

What is Tigecycline for Injection?
Tigecycline for Injection is a sterile lyophilized formulation of tigecycline, a glycylcycline-class antibiotic structurally related to tetracyclines. It is widely used for the treatment of complicated bacterial infections caused by multidrug-resistant organisms, including MRSA, VRE, and resistant Gram-negative bacteria.
 
Uses of Tigecycline for Injection
• Complicated intra-abdominal infections
• Complicated skin and skin structure infections
• Community-acquired bacterial pneumonia
• Infections caused by multidrug-resistant organisms (e.g., MRSA, VRE)
• Last-line option when other antibiotics fail
• Or as directed by physician
 
How Does Tigecycline for Injection Work?
Tigecycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the incorporation of amino acids into peptide chains. This action stops bacterial growth and controls infection effectively, even in resistant strains.
 
 
Frequently Asked Questions (FAQs)
Q: What is Tigecycline for Injection used for?
A: Tigecycline for Injection is a broad-spectrum glycylcycline antibiotic. It is primarily used to treat complicated skin and soft tissue infections (cSSTI), complicated intra-abdominal infections (cIAI), and community-acquired bacterial pneumonia (CABP). It is particularly effective against multidrug-resistant (MDR) organisms like MRSA and VRE.
Q: Who is a top manufacturer of Tigecycline for Injection in India?
A: Farbe Firma Pvt. Ltd. is a leading manufacturer and supplier of Tigecycline for Injection (Trade Name: Tigesyl). We manufacture this lyophilized antibiotic in our WHO-GMP certified facility, ensuring high stability and potency for treating resistant bacterial infections in critical care settings.
Q: In what strength and packing is Tigesyl (Tigecycline) available?
A: We manufacture Tigecycline for Injection in the standard strength of 50 mg. It is supplied as a lyophilized powder in glass vials, which requires reconstitution with a suitable diluent before intravenous infusion.
Q: How does Tigecycline differ from older tetracyclines?
A: Tigecycline is structurally modified to overcome two major mechanisms of tetracycline resistance: ribosomal protection and efflux pumps. This makes it effective against bacteria that have developed resistance to older antibiotics, making it a crucial "last-line" option in hospitals.
Q: Do you offer Contract Manufacturing for Tigecycline Injection?
A: Yes, Farbe Firma Pvt. Ltd. offers specialized Contract Manufacturing (CMO) services for lyophilized injectables like Tigecycline. We provide complete support, including stability studies, sterile manufacturing, and regulatory dossier compilation (CTD/ACTD) to help you launch the product globally.
 
Looking for a reliable Tigecycline for Injection manufacturer ?
Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and export supplies.